Page results
-
UCLH Director of Research Professor Bryan Williams has been elected as the next President of the International Society of Hypertension (ISH).
-
Whilst the UCLH paediatric emergency department remains on divert, access for GPs to paediatrics remains available as usual.
-
We are asking patients to follow some protocols before they come to UCLH and would appreciate it if you could reiterate this with your patients when you refer them.
-
Dental extractions: post-operative instructions patient information page.
-
The psychology team are running this workshop that uses a strengths based narrative approach to enable young people in years 10-13 to discuss the stresses surrounding exams and the additional challenges that having health problems add.
-
The court has granted permission to appeal a High Court ruling relating to puberty-blocking treatment in cases of gender dysphoria.
-
UCLH and The Francis Crick Institute have formed a partnership to deliver a new large-scale COVID-19 vaccination centre at the Institute.
-
"Patient-initiated follow-up” appointments (PIFU ) allow you to arrange a follow-up appointment if and when you need it.
-
COVID-19 vaccines are effective for most cancer patients but the level of protection offered by vaccines against infection, hospitalisation and death is lower compared with the general population and also wanes more quickly, according to a study in which UCLH participated.
File results
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0083 - Software systems/ suppliers used at Trust
-
FOI/2023/0086 - Number/ wait times for MRI scans for multiple sclerosis/ dementia/ prostate/ pancreatic cancer
-
FOI/2021/0284 - Sleep respiratory service
-
FOI/2023/0099 - Number of autoclaves used at Trust
-
FOI/2023/0101 - Trauma protocols in pregnant patients
-
FOI/2023/0103 - Genetic Haemochromatosis patients
-
FOI/2023/0105 - Maternity services birthing centre
-
FOI/2023/0109 - UK-EU aggrement S2 funding applications and treatments